Session Type
Industry Session
Date
Wed, 06.10.2021
Session Time
11:15 - 12:15
Room
Industry Hall 1
Chair(s)
  • Andrea Doria (Italy)
  • Anca Askanase (United States of America)
Session Description
An agenda for change: reshaping the patient pathway to TRANSFORM LUPUS - Symposium supported by AstraZeneca

Session Description

Symposium objectives: Emphasise the unmet needs in lupus and the impact these have on patients’ lives. Discuss the novel management strategies available in lupus that may improve patient outcomes. Identify key areas where there is a need for reform or action within the lupus patient pathway and consider how this may be achieved.

An agenda for change: reshaping the patient pathway to TRANSFORM LUPUS

Lecture Time
11:15 - 11:15

Supported by AstraZeneca

Lecture Time
11:15 - 11:15

Welcome: underlining the agenda for change in lupus

Presenter
  • Anca Askanase (United States of America)
  • Andrea Doria (Italy)
Lecture Time
11:15 - 11:25

Where we are now: understanding unmet needs in lupus

Presenter
  • Anca Askanase (United States of America)
Lecture Time
11:25 - 11:35

Live panel discussion

Presenter
  • Anca Askanase (United States of America)
  • Andrea Doria (Italy)
  • George Bertsias (Greece)
  • Edward M. Vital (United Kingdom)
Lecture Time
11:35 - 11:45

Where we want to be: optimising rheumatology management to drive better patient outcomes

Presenter
  • Andrea Doria (Italy)
Lecture Time
11:45 - 12:00

Live panel discussion

Presenter
  • Anca Askanase (United States of America)
  • Andrea Doria (Italy)
  • George Bertsias (Greece)
  • Edward M. Vital (United Kingdom)
Lecture Time
12:00 - 12:10

How we get there: the TRANSFORM LUPUS programme

Presenter
  • Anca Askanase (United States of America)
  • Andrea Doria (Italy)
Lecture Time
12:10 - 12:15